15-63597705-G-C
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_001367807.1(FBXL22):c.313G>C(p.Glu105Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000157 in 1,597,386 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E105K) has been classified as Uncertain significance.
Frequency
Consequence
NM_001367807.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FBXL22 | NM_001367807.1 | c.313G>C | p.Glu105Gln | missense_variant | Exon 1 of 2 | ENST00000638704.2 | NP_001354736.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FBXL22 | ENST00000638704.2 | c.313G>C | p.Glu105Gln | missense_variant | Exon 1 of 2 | 2 | NM_001367807.1 | ENSP00000492359.1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152210Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000818 AC: 2AN: 244450Hom.: 0 AF XY: 0.0000151 AC XY: 2AN XY: 132430
GnomAD4 exome AF: 0.0000166 AC: 24AN: 1445058Hom.: 0 Cov.: 31 AF XY: 0.0000182 AC XY: 13AN XY: 715926
GnomAD4 genome AF: 0.00000656 AC: 1AN: 152328Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74480
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.313G>C (p.E105Q) alteration is located in exon 1 (coding exon 1) of the FBXL22 gene. This alteration results from a G to C substitution at nucleotide position 313, causing the glutamic acid (E) at amino acid position 105 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at